 NASHUA, N.H., June 06, 2022 GLOBE NEWSWIRE -- iCAD, Inc. NASDAQ: ICAD, a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the Company will participate in the JMP Securities Life Sciences Conference, taking place June 15-16, 2022 in New York City. 